Reports for DABIGATRAN ETEXILATE

Ingredient

DABIGATRAN ETEXILATE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DABIGATRAN 75MG CAPSULE Resolved 2020-07-08 2020-09-01 119756
APO-DABIGATRAN 75MG CAPSULE Resolved 2024-06-13 2024-07-19 230477
APO-DABIGATRAN 110MG CAPSULE Resolved 2019-06-26 2022-10-07 87509
APO-DABIGATRAN 110MG CAPSULE Resolved 2022-11-20 2023-01-20 175318
APO-DABIGATRAN 110MG CAPSULE Resolved 2024-02-09 2024-02-23 219152
APO-DABIGATRAN 110MG CAPSULE Resolved 2024-06-14 2024-09-20 230561
APO-DABIGATRAN 110MG CAPSULE Actual shortage 2024-11-15 2024-11-15 243170
APO-DABIGATRAN 110MG CAPSULE Resolved 2024-12-05 2025-01-24 244888
APO-DABIGATRAN 110MG CAPSULE Resolved 2025-04-10 2025-05-23 254858
APO-DABIGATRAN 150MG CAPSULE Resolved 2020-04-13 2021-01-26 111898

Showing 1 to 10 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PRADAXA 75MG CAPSULE Discontinued 2025-04-17 2025-10-25 255171
PRADAXA 110MG CAPSULE Discontinued 2017-12-21 2017-12-21 34114
PRADAXA 150MG CAPSULE Discontinued 2017-10-19 2017-10-19 26385

Showing 1 to 3 of 3